38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty
Online press conference today with Mary Robinson, President, Realizing
Rights, the ethical global initiative, Salil Shetty (UNMC) and Kumi Naidoo
(GCAP) at 14.00GMT - log on at http://www.standagainstpoverty.org/press/conference
NEW YORK, Oct. 18 /PRNewswire-USNewswire/ -- Over 38.7 millio...
Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee
US Speed Skater Hopes to Educate Women About this Common Condition
MILWAUKEE, Sept. 13 /PRNewswire/ -- US speed skater Bonnie Blair will
be at the Hyatt Regency Milwaukee hotel (333 West Kilbourn Avenue,
Milwaukee) on October 25, 2007 from 6:30 pm to 7:30 pm to talk about her
experience wit...
Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
...n monoclonal antibody in late stage clinical development that specifically targets RANK Ligand, the essential regulator of osteoclasts (the cells that
break down bone). With more than 19,000 patients in trials across indications worldwide, the denosumab development program is the largest ever initiated by ...
Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
...ke me must be proactive about how they manage their bone health before they
break a bone. I encourage them to be more proactive in speaking with their docto... bone will fracture again within a year(13)
Half of the women who
break a hip will permanently need assistance to walk(14)
Nearly one in...
Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
...n monoclonal antibody in late stage clinical development that specifically targets RANK Ligand, the essential regulator of osteoclasts (the cells that
break down bone). With more than 19,000 patients in trials across indications worldwide, the denosumab development program is the largest ever initiated by ...
Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
...l is designed to selectively bind to and stabilize a-Gal A, which facilitates proper trafficking of the enzyme to the lysosomes, where it is needed to
break down GL-3.
Fabry disease is estimated to affect approximately 5,000 to 10,000 people in the developed world, but recent evidence suggests that t...
Glybera(TM) Shows Long-Term Health Benefits
...s caused by mutations in the LPL
gene, resulting in highly decreased or absent activity of LPL protein in
patients. This protein is needed in order to
break down large fat-carrying
particles that circulate in the blood after each meal. When such particles,
called chylomicrons, accumulate in the blood, they...
Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development
...factor of all journals of clinical medicine; in 2006, the impact factor was 51, according to Journal Citation Reports , the first research journal to
break 50.
...
Glycerin Proven to Improve Bruising and Swelling Caused By Trauma to Skin
...tant, attracts water and helps lubricate and hydrate the skin's cells. It is a thick, water-soluble liquid. Bruises occur when capillary blood vessels
break and blood and fluids pool underneath the skin. Glycerin's hydrating properties enable the body to seal off the broken capillaries and blood vessels ca...
Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin
...out PATH
PATH is an international nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to
break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, PATH helps provide appropriate health technolog...
Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
... supported by PATH - a U.S.-based non-profit organization that creates sustainable, culturally relevant solutions that enable communities worldwide to
break longstanding cycles of poor health. Having supported the preclinical studies of the IC47 vaccine, PATH has now committed another USD 3.6 m for the fur...
Oh, My Aching Back: Give Me a Shot of Ozone
...isks. When these disks are healthy, they act as shock absorbers for the spine and keep the spine flexible. But when a disk is damaged, it may bulge or
break open. "There are millions of people with back pain who suffer and who can't work because of their pain. Undergoing invasive surgical diskectomy puts y...
CEL-SCI Corporation Releases Letter to Shareholders
...
Multikine was named one of 10 future blockbuster drugs by MedAdNews . "These 10 medicines are expected to eventually garner FDA approval and
break the annual billion-dollar sales barrier."
At the end of 2008 we took delivery of the Multikine manufacturing facility i...
Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
...udy, which was a Phase 2 double-blind, placebo-controlled, randomized trial of alagebrium in patients with chronic systolic heart failure;
- the
break study, which was a Phase 2 double-blind, placebo-controlled, randomized trial of alagebrium in patients with diastolic heart failure; and
- the P...
Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
.... Bianco, M.D.
Chief Executive Officer of CTI. "With the potential for three drug approvals
in 2009 we are on track to meet our objective of cash flow
break even in the
fourth quarter of this year."
The EXTEND clinical trial was a phase III single-agent trial of pixantrone
for patients with relapsed...
Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research
...
Clot-busting drugs only work about half of the time because the blockage can be sticky and adhere to the wall of the artery, making it difficult to
break up, said Dr. Hopkins.
Researchers used computed tomography (CT) perfusion to determine if the use of a stent would be beneficial. "With CT perfu...
Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa
...d in 1977, PATH is an international,
nonprofit organization that creates sustainable, culturally relevant
solutions, enabling communities worldwide to
break longstanding cycles of poor
health. By collaborating with diverse public- and private-sector partners,
PATH helps provide appropriate health technolog...
New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation
...eat inconsistently and rapidly. When this
happens, blood can become stagnant near the walls of the atria and form blood
clots. These blood clots can
break off and travel through the blood stream to
the brain where they can plug blood vessels possibly causing a stroke. These
clots can also cause damage t...
Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation
...eat inconsistently and rapidly. When this
happens, blood can become stagnant near the walls of the atria and form blood
clots. These blood clots can
break off and travel through the blood stream to
the brain where they can block blood vessels possibly causing a stroke. These
clots can also cause damage ...
Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting
...a and lymphoma. The embargo for this abstract will
break at that time.
Results from this multinati...a and lymphoma. The embargo for this abstract will
break at that time.
This research unveiled a ne...e cell disease. The embargo for this abstract will
break at that time.
The results of this phase I...
Gene Therapy Corrects Sickle Cell Disease in Laboratory Study
... in the gene for beta-globin, a protein component of hemoglobin. This defect causes hemoglobin-containing red blood cells to tend to deform, clump and
break apart. The resulting clogged blood vessels can lead to cognitive dysfunction by causing small strokes in the brain and cause damage to kidneys, liver,...
New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties
... Linden
Plainfield City
Roselle Boro
The advisory was issued as a precautionary measure resulting from a water main
break in the area. Analytical results from bacteriological samples taken from the water system met all state and federal water quality standards.
N...
Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
...eter-directed thrombolysis
(CDT) techniques. It provides an important adjunct to anti-coagulation alone,
the current standard of care, which does not
break up the existing clot but
simply prevents further clot from forming.
Alan M. Dietzek, MD, Chief of Vascular and Endovascular Surgery at Danbury
Hos...
CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
...clude patients from CEL-SCI's
Pivotal global Phase III clinical trial.
"Multikine's potential to change the tumor microenvironment and, in
doing so,
break tumor tolerance has been a long-time goal of anti-cancer
immunotherapy. We are very excited to be working with Dr. Marincola and the
NIH Clinical Cent...
Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs
...tham. PCDT combines
the use of a clot-dissolving drug with a catheter-mounted miniature clot
removal device, allowing an interventional radiologist to
break up the clot
and remove it from the vein, restoring blood flow. "PTS is a serious
complication of DVT that is under recognized and potentially preventa...
September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging
... to consider surgery, the only treatment.
The most common surgical approach is called phacoemulsification. An
ultrasound probe is used to soften and
break up the clouded lens, which is
suctioned out. Then, the surgeon inserts an artificial flexible lens. The
outpatient procedure involves minimal anesthes...
Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test
...e against high-resistant agents cannot be won with the
previous means, such as the use of new antibiotics and intensive
disinfection measures. We must
break new grounds in order to reduce the
potential danger for our patients," Professor Prof. Dr. med. Jorg Braun,
chief physician of the I. Medical Departme...
'Snapshots' of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
...before symptoms can be detected
clinically.
"Increased FA activity is the earliest indicator that cell death has
occurred and tissue is beginning to
break down," says Petty, professor of
Ophthalmology and Visual Sciences, and professor of Microbiology and
Immunology at the U-M Medical School. "FA serves ...
Stroke Study Reveals a Key Target For Improving Treatment
...eptor, apparently counteracting tPA's effect.
This unwanted effect on the blood-brain barrier appears to be unrelated
to tPA's main job, which is to
break down clots that have lodged in the
brain's blood vessels, cutting off blood supply to the area and starving
brain tissue until it begins to die.
Suc...
Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
...e-free.
Zometa slows the bone-destroying effect that occurs with bone
metastases by fighting abnormal activation of osteoclasts, cells that
normally
break down old bone, and osteoblasts, cells that normally build
new bone. Growth factors produced by cancer cells overstimulate osteoclasts
and osteoblasts,...
AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011
...py product that corrects the genetic defect
in lipoprotein-lipase (LPL) deficient patients. LPL is normally produced in
muscle tissue and is needed to
break down the large fat-carrying particles
that circulate in the blood after each meal. As a result, LPL-deficient
patients have very high fat (triglycerid...
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
...m .
About Hunter Syndrome
Hunter syndrome (MPS II) is a serious genetic disorder mainly affecting
males that interferes with the body's ability to
break down and recycle
waste substances called mucopolysaccharides, also known as
glycosaminoglycans or GAG. Hunter syndrome is one of several related
lysos...
Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
... 8:00 a.m. - 12:00 p.m. Exhibit Hall B-F, San Diego Convention Center -- Sensitivity to SNS-595 is related to activation of double strand DNA
break repair pathways including homologous recombination Session: Stress Responses Abstract #1859 8:00 a.m. - 12:00 p.m. Exhibit Hall B-F, San D...
Filter Fails to Improve PCI Outcomes in Acute Coronary Syndromes
...id damage to heart muscle
CHICAGO, March 30 /PRNewswire/ -- A device that catches bits of plaque
and blood clot that
break loose during percutaneous coronary intervention
(PCI) has failed to show that it can reduce rates of major cardiovascular
complications in patients wi...
Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of 'Knock-Out' Cell Lines
...e gene is
specifically knocked out. ZFNs were used to place a double strand
break in
the DNA sequence precisely within the gene to be eliminated. The process...ess often results in a small amount
of DNA being deleted at the site of the
break and the consequent disruption
of the expression of the gene and the protein...
Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
...techniques. It provides an important
adjunct to the standard therapy of anti-coagulation alone, which is
intended to prevent future clots but does not
break up the existing clot.
Gerard O'Sullivan, MD, Interventional Radiologist from University
Hospital in Galway, Ireland, reported the latest outcomes fr...
New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry
...lot-busting drugs with a drug
dispersion device to
break up the clot, providing interventional
radiologists with physical assistance to
break up the clot faster. Because
the device disperses t...hinners), which prevents future clots but does not
break up the existing
clot.
DVT can lead to serious ...
Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
...sed on rHuPH20, a recombinant form of hyaluronidase, a naturally
occurring human enzyme. The rHuPH20 mechanism of action is its ability to
temporarily
break down hyaluronic acid, the space-filling "gel"-like
substance that is a major component of subcutaneous tissues. When combined
or co-formulated with ce...
Gates Foundation Seeks Proposals for Innovative Global Health Research
...ntional approaches to understanding latent TB infection, with the goal of discovering new ways to identify and eliminate latent infection, and
break the cycle of TB transmission.
Grant proposals for the first Explorations funding round will be
accepted online at http://www.gcgh.org/explorati...
ImaRx Therapeutics Transitions Business Strategy
...care institutions.
About SonoLysis
ImaRx's SonoLysis program involves the administration of its
proprietary MRX-801 microbubbles and ultrasound to
break up blood clots and
restore blood flow to oxygen deprived tissues. The sub-micron size of
MRX-801 microbubbles may allow them to penetrate a blood clot...